<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">mSphere</journal-id><journal-id journal-id-type="iso-abbrev">mSphere</journal-id><journal-id journal-id-type="pmc-domain-id">2989</journal-id><journal-id journal-id-type="pmc-domain">msphere</journal-id><journal-id journal-id-type="publisher-id">mSphere</journal-id><journal-title-group><journal-title>mSphere</journal-title></journal-title-group><issn pub-type="epub">2379-5042</issn><publisher><publisher-name>American Society for Microbiology (ASM)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC4933989</article-id><article-id pub-id-type="pmcid-ver">PMC4933989.1</article-id><article-id pub-id-type="pmcaid">4933989</article-id><article-id pub-id-type="pmcaiid">4933989</article-id><article-id pub-id-type="pmid">27390779</article-id><article-id pub-id-type="doi">10.1128/mSphere.00099-16</article-id><article-id pub-id-type="publisher-id">mSphere00099-16</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Minireview</subject><subj-group><subject>Host-Microbe Biology</subject></subj-group></subj-group></article-categories><title-group><article-title>Potential Roles of Fungal Extracellular Vesicles during Infection</article-title><alt-title alt-title-type="running-head">Minireview</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Joffe</surname><given-names initials="LS">Luna S.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nimrichter</surname><given-names initials="L">Leonardo</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6081-3439</contrib-id><name name-style="western"><surname>Rodrigues</surname><given-names initials="ML">Marcio L.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Del Poeta</surname><given-names initials="M">Maurizio</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><aff id="aff1"><label>a</label>Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de G&#243;es, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil</aff><aff id="aff2"><label>b</label>Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, USA</aff><aff id="aff3"><label>c</label>Centro de Desenvolvimento Tecnol&#243;gico em Sa&#250;de (CDTS) da Funda&#231;&#227;o Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil</aff><aff id="aff4"><label>d</label>Veterans Administration Medical Center, Northport, New York, USA</aff></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Blader</surname><given-names initials="IJ">Ira J.</given-names></name><role>Editor</role><aff>University at Buffalo</aff></contrib></contrib-group><author-notes><corresp id="cor1">Address correspondence to Maurizio Del Poeta, <email>maurizio.delpoeta@stonybrook.edu</email>.</corresp><fn fn-type="other"><p><bold>Citation</bold> Joffe LS, Nimrichter L, Rodrigues ML, Del Poeta M. 2016. Potential roles of fungal extracellular vesicles during infection. mSphere 1(4):e00099-16. doi:<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/mSphere.00099-16">10.1128/mSphere.00099-16</ext-link>.</p></fn></author-notes><pub-date pub-type="epub"><day>29</day><month>6</month><year>2016</year></pub-date><pub-date pub-type="collection"><season>Jul-Aug</season><year>2016</year></pub-date><volume>1</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">272095</issue-id><elocation-id>e00099-16</elocation-id><pub-history><event event-type="pmc-release"><date><day>29</day><month>06</month><year>2016</year></date></event><event event-type="pmc-live"><date><day>07</day><month>07</month><year>2016</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-07-22 19:25:22.577"><day>22</day><month>07</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2016 Joffe et al.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Joffe et al.</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="mSphere.00099-16.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="sph004162106001.pdf"/><abstract abstract-type="precis"><p>Extracellular vesicles (EVs) are produced by virtually all cell types. Within the past few years, work in this field has revealed more information about fungal EVs. Fungal EVs have been shown to carry proteins, lipids, pigments, polysaccharides, and RNA; these components are known virulence factors, a fact which supports the hypothesis that fungal EVs concentrate pathogenic determinants.</p></abstract><abstract><title>ABSTRACT</title><p>Extracellular vesicles (EVs) are produced by virtually all cell types. Within the past few years, work in this field has revealed more information about fungal EVs. Fungal EVs have been shown to carry proteins, lipids, pigments, polysaccharides, and RNA; these components are known virulence factors, a fact which supports the hypothesis that fungal EVs concentrate pathogenic determinants. Additionally, recent studies have demonstrated that fungal EVs stimulate the host immune system. In this review, putative roles of fungal EVs are discussed, including their potential as vaccination tools and their possible contribution to pathogenesis in invasive fungal diseases.</p></abstract><kwd-group><title>KEYWORDS:</title><kwd>Fungal pathogenesis</kwd><kwd>vesicles</kwd><kwd>ceramide</kwd><kwd>fungi</kwd><kwd>glycolipids</kwd><kwd>sphingolipids</kwd></kwd-group><counts><fig-count count="2"/><table-count count="0"/><equation-count count="0"/><ref-count count="92"/><page-count count="10"/><word-count count="6682"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>July/August 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="h0.0"><title>INTRODUCTION</title><p>Extracellular vesicles (EVs) are membranous compartments that are released by all living cells investigated so far. EVs play important roles in nutrition, physiopathogenesis, and cell-to-cell communication (<xref rid="B1" ref-type="bibr">1</xref>). EVs are now considered key mediators of immunopathogenesis in bacteria, fungi, and protozoa, which has encouraged research activity in this field (<xref ref-type="fig" rid="fig1">Fig.&#160;1)</xref>. Currently, the majority of the literature concerning EVs is specific to bacterial cells.</p><fig id="fig1" orientation="portrait" position="float"><label>FIG&#160;1&#160;</label><caption><p>Numbers of publications (peer-reviewed articles, book chapters, reviews, notes, conference reviews) related to EVs produced by bacterial, fungal, and parasite organisms. The Scopus database was used to track microbial EV-related publications from 1980 to 2015. The keywords &#8220;fungal/fungi/yeast extracellular vesicles,&#8221; &#8220;bacterial/bacteria extracellular vesicles,&#8221; and &#8220;parasite/protozoan/protozoa extracellular vesicles&#8221; were used for article searches in titles, abstracts, and keywords.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="sph0011621060001.jpg"/></fig><p>EVs are composed of lipid bilayers, and they range in size from 30 to 1,000&#160;nm (<xref rid="B2" ref-type="bibr">2</xref><xref ref-type="bibr" rid="B3">&#8211;</xref><xref rid="B5" ref-type="bibr">5</xref>). The dimensions and composition of EVs are determined by their mechanisms of biogenesis, which are classified into compartments: exosomes, microvesicles (also called ectosomes), and apoptotic bodies (<xref rid="B6" ref-type="bibr">6</xref>). Exosomes originate from the endocytic pathway and are the smallest vesicles, being approximately 30 to 100&#160;nm in size. Microvesicles are released from cells through membrane shedding, and their dimensions range from 100 to 1,000&#160;nm (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). Lastly, apoptotic bodies are shed from the plasma membrane of cells during programmed death and usually are the largest EVs, ranging from 800 to 1,000&#160;nm in size (<xref rid="B8" ref-type="bibr">8</xref>). This review discusses the relationship between the composition and biological functions of fungal EVs and addresses the roles of EVs in fungal pathogenesis and their potential biological activity as therapeutic and prophylactic tools.</p></sec><sec id="h1"><title>MICROBIAL EXTRACELLULAR VESICLES</title><p>It is still unclear how EVs are released by cell wall-containing microorganisms, including Gram-positive bacteria, mycobacteria, and fungi (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>). EV cargo in these microorganisms includes enzymes, nucleic acids, polysaccharides, pigments, lipoproteins, and toxins (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B11" ref-type="bibr">11</xref><xref ref-type="bibr" rid="B12">&#8211;</xref><xref rid="B14" ref-type="bibr">14</xref>). Both shared EV cargo and organism-specific EV cargo have been characterized, in association with organism-related differences in dimensions (<xref ref-type="fig" rid="fig2">Fig.&#160;2)</xref>.</p><fig id="fig2" orientation="portrait" position="float"><label>FIG&#160;2&#160;</label><caption><p>Schematic presentation of EVs produced by different microbial cells. OMP, outer membrane protein; GlcConj., glycoconjugates; GSL, glycosphingolipids; ERG, ergosterol; LPS, lipopolysaccharide.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="sph0011621060002.jpg"/></fig></sec><sec id="h2"><title>BACTERIAL VESICLES</title><p>In bacteria, EVs have been most well studied in Gram-negative cells. The first reports of EV characterization were in <italic toggle="yes">Escherichia coli</italic> in the 1960s (<xref rid="B15" ref-type="bibr">15</xref><xref ref-type="bibr" rid="B16">&#8211;</xref><xref rid="B18" ref-type="bibr">18</xref>). Gram-negative EVs are also known as outer membrane vesicles (OMVs), due to their site of biogenesis (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B19" ref-type="bibr">19</xref>). OMVs can increase bacterial resistance to antibiotics and phages by serving as decoy targets for these molecules (<xref rid="B19" ref-type="bibr">19</xref>). They can also transfer DNA between cells and carry enzymes that degrade antibiotics (<xref rid="B19" ref-type="bibr">19</xref>). Gram-negative OMVs participate in the interaction of bacteria with host cells during infection. They deliver virulence factors, such as toxins, into host cells, including immune cells (<xref rid="B19" ref-type="bibr">19</xref>). OMV production is also known to be important for stress responses and nutrient acquisition for bacteria (<xref rid="B11" ref-type="bibr">11</xref>). While OMVs have been shown to play a role in bacterial virulence, they can also be harnessed as a potential vaccine tool. Some applications of OMVs as vaccines have already been approved for use in humans or are in clinical trials (<xref rid="B20" ref-type="bibr">20</xref><xref ref-type="bibr" rid="B21">&#8211;</xref><xref rid="B23" ref-type="bibr">23</xref>).</p><p>EVs released by Gram-positive bacteria differ from those released by Gram-negative EVs cells due to the lack of outer membranes and the presence of a thicker peptidoglycan layer (<xref rid="B24" ref-type="bibr">24</xref>). The mechanisms by which Gram-positive EVs are released are still not clear, but it is known that they carry cell wall hydrolases and peptidoglycan-degrading enzymes, suggesting that gaps might be formed in cell wall layers in order to release EVs (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B25" ref-type="bibr">25</xref><xref ref-type="bibr" rid="B26">&#8211;</xref><xref rid="B27" ref-type="bibr">27</xref>). Gram-positive species releasing EVs include <italic toggle="yes">Staphylococcus aureus</italic> (<xref rid="B28" ref-type="bibr">28</xref>), <italic toggle="yes">Bacillus subtilis</italic> (<xref rid="B29" ref-type="bibr">29</xref>), <italic toggle="yes">Streptococcus pneumoniae</italic> (<xref rid="B26" ref-type="bibr">26</xref>), <italic toggle="yes">Bacillus anthracis</italic> (<xref rid="B12" ref-type="bibr">12</xref>), and <italic toggle="yes">Listeria monocytogenes</italic> (<xref rid="B30" ref-type="bibr">30</xref>). Virulence factors of Gram-positive bacteria, including enzymes (&#946;-lactamases, hemolysin, and coagulase) and toxins (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B31" ref-type="bibr">31</xref>), are also released into the extracellular milieu through EVs. Work done with <italic toggle="yes">B.&#160;anthracis</italic> EVs efficiently illustrates how toxin components essential for virulence are released into host cells inside vesicles (<xref rid="B12" ref-type="bibr">12</xref>).</p><p>EVs released by Gram-positive bacteria are potentially emerging as vaccine components. Rivera and colleagues have shown that toxins released inside <italic toggle="yes">B.&#160;anthracis</italic> EVs induced robust immune responses in BALB/c mice that led to higher survival rates in animals challenged with the pathogen (<xref rid="B12" ref-type="bibr">12</xref>)<italic toggle="yes">.</italic> Similar results were observed with <italic toggle="yes">Mycobacterium tuberculosis</italic> EVs (<xref rid="B32" ref-type="bibr">32</xref>). Mice immunized with mycobacterial EVs induced strong T helper type 1&#160;cell responses (Th1), elicited antibody production, and reduced bacterial burden (<xref rid="B32" ref-type="bibr">32</xref>).</p></sec><sec id="h3"><title>PROTOZOAN VESICLES</title><p>Parasite EVs were first described more than 20&#160;years ago, although their relevance for secretory mechanisms has been realized only recently (<xref rid="B33" ref-type="bibr">33</xref>). In <italic toggle="yes">Leishmania</italic> spp. and <italic toggle="yes">Trypanosoma cruzi</italic>, EVs play important roles in protein export pathways, macrophage communication, and inflammatory responses (<xref rid="B34" ref-type="bibr">34</xref><xref ref-type="bibr" rid="B35">&#8211;</xref><xref rid="B36" ref-type="bibr">36</xref>). Proteomic analysis in <italic toggle="yes">T.&#160;cruzi</italic> has shown the presence of a great number of proteins containing nucleic acid-binding sites and ribosomal proteins within EVs (<xref rid="B37" ref-type="bibr">37</xref>). Different types of small RNAs were also detected in parasite EVs (<xref rid="B38" ref-type="bibr">38</xref>). Additionally, there were found to be differences between small RNAs packaged in EVs in each parasite developmental form (<xref rid="B38" ref-type="bibr">38</xref>). It has been demonstrated that <italic toggle="yes">T.&#160;cruzi</italic> (<xref rid="B39" ref-type="bibr">39</xref>) and <italic toggle="yes">Plasmodium falciparum</italic> (<xref rid="B40" ref-type="bibr">40</xref>) can transfer genetic information between parasites and from parasites to mammalian host cells. More recently, Fernandez-Calero and colleagues suggested that, under conditions of nutritional stress, a specific type of small RNA is released into EVs that may play a role in parasite-host interaction (<xref rid="B41" ref-type="bibr">41</xref>). In <italic toggle="yes">Leishmania</italic> spp., EV release is considered the most important mechanism of protein secretion and mediates delivery of parasite proteins into macrophages to cause production of interleukin-8 (IL-8) (<xref rid="B35" ref-type="bibr">35</xref>). Accordingly, EVs may increase parasite virulence; thus, pretreatment of mice with <italic toggle="yes">T.&#160;cruzi</italic> EVs followed by intraperitoneal parasite inoculation resulted in mortality indices that were higher than those seen with untreated mice (<xref rid="B34" ref-type="bibr">34</xref>). Moreover, EVs induced increased heart parasitism and inflammation through enhanced IL-10 and IL-4 production (<xref rid="B34" ref-type="bibr">34</xref>). These data suggested that <italic toggle="yes">T.&#160;cruzi</italic> EVs could facilitate parasite dissemination and pathogenic mechanisms (<xref rid="B34" ref-type="bibr">34</xref>). More recently, Szempruch and colleagues demonstrated that African trypanosomes release EVs through flagellum-derived nanotube formation, resulting in vesicular fusion with mammalian erythrocytes, membrane disruption, and anemia (<xref rid="B42" ref-type="bibr">42</xref>). Together, these results indicate that parasite EVs might participate in mechanisms of either virulence or immune response modulation in parasitic infections.</p></sec><sec id="h4"><title>FUNGAL VESICLES</title><p>EVs produced by fungal cells are peculiar because, like bacterial EVs, fungal EVs must traverse a cell wall in order to be released. The mechanisms of EV release across the complex molecular network of the fungal cell wall are still unknown. Wolf and colleagues have utilized electron microscopy techniques to suggest that EVs interact with cell wall components (<xref rid="B43" ref-type="bibr">43</xref>). They showed that single and multiple vesicles simultaneously gain access to the extracellular milieu by crossing of the cell wall (<xref rid="B43" ref-type="bibr">43</xref>). The cellular origin of fungal EVs remains unknown. Rodrigues and colleagues suggested that EVs could originate from cytoplasmic subtractions (<xref rid="B44" ref-type="bibr">44</xref>). Other studies indicated that multivesicular bodies and membrane budding may also participate in EV formation (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B45" ref-type="bibr">45</xref>). These mechanisms are compatible with the presence of cytoplasmic proteins lacking secretory signals in EVs (<xref rid="B44" ref-type="bibr">44</xref>). The mechanisms of passage through the cell wall are similarly unknown. Proteomic analysis of EVs from <italic toggle="yes">Saccharomyces cerevisiae</italic>, <italic toggle="yes">Histoplasma capsulatum</italic>, <italic toggle="yes">Paracoccidioides brasiliensis</italic>, <italic toggle="yes">Candida albicans</italic>, and <italic toggle="yes">Cryptococcus neoformans</italic> revealed the presence of cell wall-degrading enzymes, suggesting that EV-associated molecules could be present in vesicular membranes and thus exposed, catalyzing cell wall crossing by hydrolysis of structural components (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B46" ref-type="bibr">46</xref><xref ref-type="bibr" rid="B47">&#8211;</xref><xref rid="B49" ref-type="bibr">49</xref>).</p><p>EVs transport virulence-associated components to the extracellular medium, suggesting that they are required for fungal pathogenesis (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B50" ref-type="bibr">50</xref>). In contrast, EVs have been shown to induce protection in experimental models of fungal infection (<xref rid="B13" ref-type="bibr">13</xref>). In the following sections, possible roles of fungal EVs as &#8220;virulence bags&#8221; and their potential as vaccine tools are discussed.</p></sec><sec id="h5"><title>EV CARGO IN FUNGI</title><p>Components of fungal EVs, including lipids (neutral glycolipids, sterols, and phospholipids), polysaccharides (glucuronoxylomannan [GXM] and &#945;-galactosyl epitopes and mannose and N-acetylglucosamine residues), proteins (lipases, proteases, phosphatase, urease, laccase, and many others), and nucleic acids (different RNA species) have been described as virulence factors in different fungal species (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B47" ref-type="bibr">47</xref><xref ref-type="bibr" rid="B48">&#8211;</xref><xref rid="B52" ref-type="bibr">52</xref>). In <italic toggle="yes">C.&#160;neoformans</italic> and <italic toggle="yes">C.&#160;albicans</italic>, mass spectrometry and high-performance thin-layer chromatography (HPTLC) analysis revealed the presence of glucosylceramide (GlcCer) and sterols in EVs (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B13" ref-type="bibr">13</xref>). In addition, lipidomic analysis of <italic toggle="yes">P.&#160;brasiliensis</italic> EVs revealed the presence of GlcCer, brassica sterol, ergosterol, and lanosterol in different strains (<xref rid="B53" ref-type="bibr">53</xref>). GlcCer is a well-known virulence determinant of <italic toggle="yes">C.&#160;neoformans</italic>, since mutant cells lacking GlcCer synthase were avirulent in a murine model of cryptococcosis (<xref rid="B54" ref-type="bibr">54</xref>). <italic toggle="yes">C.&#160;albicans</italic> mutants lacking GlcCer biosynthesis were hypovirulent in BALB/c mice (<xref rid="B55" ref-type="bibr">55</xref>). In other fungi, such as <italic toggle="yes">Aspergillus nidulans</italic> and <italic toggle="yes">Fusarium graminearum</italic>, GlcCer is essential for hyphal growth and spore germination (<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B57" ref-type="bibr">57</xref>), highlighting the role of GlcCer in both yeast and filamentous fungi.</p><p>Complex carbohydrates, such as GXM, are also exported in fungal EVs (<xref rid="B48" ref-type="bibr">48</xref>). In <italic toggle="yes">P.&#160;brasiliensis</italic>, EVs contain antigenic &#945;-galactopyranosyl epitopes (<xref rid="B50" ref-type="bibr">50</xref>). Peres da Silva and colleagues have shown that residues of mannose and N-acetylglucosamine are present at the surface of <italic toggle="yes">P.&#160;brasiliensis</italic> EVs, where they mediate recognition by innate immune receptors (<xref rid="B14" ref-type="bibr">14</xref>). These observations might suggest a role for <italic toggle="yes">P.&#160;brasiliensis</italic> EVs in pathogen-host communication with the innate immune system, but it remains to be confirmed (<xref rid="B14" ref-type="bibr">14</xref>).</p><p>Fungal pigments are also found in and exported extracellularly by fungal EVs (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B52" ref-type="bibr">52</xref>). Melanin granules have dimensions that are comparable to those of EVs (<xref rid="B52" ref-type="bibr">52</xref>). In addition, melanin ghosts stained with lipophilic dyes suggested the presence of associated lipids. In fact, purified <italic toggle="yes">C.&#160;neoformans</italic> EVs contain electron-dense and dark granules (<xref rid="B48" ref-type="bibr">48</xref>) and are able to catalyze melanin synthesis in the presence of <sc>l</sc>-3,4-dihydroxyphenylalanine (L-DOPA) (<xref rid="B52" ref-type="bibr">52</xref>), strongly suggesting that melanin synthesis occurs inside fungal vesicles for further transport to the cell wall (<xref rid="B52" ref-type="bibr">52</xref>).</p><p>RNA-containing vesicles have been characterized in <italic toggle="yes">C.&#160;neoformans</italic>, <italic toggle="yes">C.&#160;albicans</italic>, <italic toggle="yes">S. cerevisiae</italic>, and <italic toggle="yes">P.&#160;brasiliensis</italic> (<xref rid="B51" ref-type="bibr">51</xref>). In these organisms, EVs carry small RNA molecules that are protected by EV membranes against exogenous RNase degradation. Mature tRNAs and mRNAs and noncoding RNAs are also present in fungal EVs (<xref rid="B51" ref-type="bibr">51</xref>). Although little is known about the function of RNAs in fungal EVs, it has been suggested that these molecules could participate in cell-to-cell communication, including host cells (<xref rid="B51" ref-type="bibr">51</xref>). This is supported by studies in <italic toggle="yes">T.&#160;cruzi</italic>, in which tRNA induces changes in host cells, making them more susceptible to infection (<xref rid="B58" ref-type="bibr">58</xref>).</p><p>Proteomic analysis of fungal EVs revealed the presence of a complex protein composition with multiple functions, including sugar metabolism, cell wall architecture, cell signaling, lipid metabolism, cell growth/division, and virulence (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B46" ref-type="bibr">46</xref><xref ref-type="bibr" rid="B47">&#8211;</xref><xref rid="B49" ref-type="bibr">49</xref>). Although many of these proteins have been shown to be shared in <italic toggle="yes">C.&#160;neoformans</italic>, <italic toggle="yes">P.&#160;brasiliensis</italic>, <italic toggle="yes">C.&#160;albicans</italic>, <italic toggle="yes">H.&#160;capsulatum</italic>, and <italic toggle="yes">S.&#160;cerevisiae</italic> EVs, species-specific protein molecules have also been abundantly observed (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B46" ref-type="bibr">46</xref><xref ref-type="bibr" rid="B47">&#8211;</xref><xref rid="B49" ref-type="bibr">49</xref>). For instance, enzymes essential to glucuronic acid metabolism were found in <italic toggle="yes">C.&#160;neoformans</italic> EVs but not in those of other species (<xref rid="B48" ref-type="bibr">48</xref>). EVs produced by fungi contain proteins such as plasma membrane ATPases, cytoskeleton proteins, heat shock proteins (HSP70 and HSP90), adhesins, and antioxidant proteins, including superoxide dismutase and catalase B (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>). The activity of urease and phosphatase was also detected in <italic toggle="yes">C.&#160;neoformans</italic> EVs (<xref rid="B48" ref-type="bibr">48</xref>). Urease is known to be an important virulence factor of <italic toggle="yes">C.&#160;neoformans</italic> in enhancing the invasion of host central nervous system (<xref rid="B59" ref-type="bibr">59</xref>). Phosphatases, which are surface components in different fungal species (<xref rid="B60" ref-type="bibr">60</xref><xref ref-type="bibr" rid="B61">&#8211;</xref><xref rid="B62" ref-type="bibr">62</xref>), were detected in other fungal EVs (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B49" ref-type="bibr">49</xref>).</p><p>In the context of all the EV cargo mentioned above, some examples of the involvement of mutants in vesicle formation can help understanding of the importance of fungal EVs. In <italic toggle="yes">C.&#160;neoformans</italic>, a Sec6 RNA interference (RNAi) mutant accumulates EVs inside the cells and the levels of some virulence factors, such as those involved in laccase, urease, and polysaccharide secretion, are significantly decreased. As a consequence, its virulence is attenuated (<xref rid="B63" ref-type="bibr">63</xref>). This was the first evidence correlating fungal EVs with virulence. Also, in <italic toggle="yes">C.&#160;neoformans</italic>, a secretion mutant called <italic toggle="yes">sav1</italic>, lacking a Sec4 GTPase homolog protein of post-Golgi secretion, accumulated EVs inside the cells and showed reduced secretion of proteins (<xref rid="B64" ref-type="bibr">64</xref>). In <italic toggle="yes">C.&#160;albicans</italic>, phosphatidylserine synthase (<italic toggle="yes">CHO1</italic>) and phosphatidylserine decarboxylase (<italic toggle="yes">PSD1</italic> and <italic toggle="yes">PSD2</italic>) mutants also showed differences in the structures and constitution of EVs (<xref rid="B65" ref-type="bibr">65</xref>), but whether this phenotype affects <italic toggle="yes">Candida</italic> virulence is not known. There are some secretion-defective mutants that have been reported in the literature, but the correlation of defects in secretion of EVs with fungal virulence has been studied by our group.</p></sec><sec id="h6"><title>FUNGAL EVs AS POTENTIAL VACCINES</title><p>There are many practical advantages to the general use of EVs as potential vaccine tools. As discussed by Schorey and coworkers (<xref rid="B7" ref-type="bibr">7</xref>), EVs offer more-stable conformational conditions for protein components, are able to circulate in body fluids, and show efficient association with antigen-presenting cells (<xref rid="B7" ref-type="bibr">7</xref>). However, fungal EVs manifest important particularities. For instance, <italic toggle="yes">C.&#160;neoformans</italic> EVs are unstable in the presence of host serum proteins (<xref rid="B66" ref-type="bibr">66</xref>).</p><p>Studies using EVs as vaccine tools initially included dendritic cell vesicles used for tumor control (<xref rid="B67" ref-type="bibr">67</xref>). Recent studies have demonstrated that EV prophylaxis induced increased survival and slower tumor development in mice (<xref rid="B68" ref-type="bibr">68</xref>). Development of vaccines using pathogen-derived EVs first included Gram-negative OMVs produced by <italic toggle="yes">Neisseria meningitidis</italic> serogroup B (<xref rid="B69" ref-type="bibr">69</xref><xref ref-type="bibr" rid="B70">&#8211;</xref><xref rid="B71" ref-type="bibr">71</xref>). Four licensed OMV vaccines are now available (<xref rid="B70" ref-type="bibr">70</xref><xref ref-type="bibr" rid="B71">&#8211;</xref><xref rid="B72" ref-type="bibr">72</xref>), each of them having been developed for a specific outbreak. Meningococcal group B vaccine (Bexsero), the most recently licensed OMV vaccine, was designed to provide broad protection through combining multiple antigens (<xref rid="B72" ref-type="bibr">72</xref>). These EV vaccines were associated with high effectiveness in regions where the circulating and vaccine strains were the same (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B73" ref-type="bibr">73</xref>). Promising studies focusing on other bacterial species are available in the current literature (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B74" ref-type="bibr">74</xref>, <xref rid="B75" ref-type="bibr">75</xref>).</p><p>Studies on the immunobiological activity of fungal EVs have been performed more recently. In 2011, it was shown that EVs in <italic toggle="yes">Malassezia sympodialis</italic> carry antigens and allergens that modulate the immune system through <italic toggle="yes">in vivo</italic> stimulation of IL-4 and tumor necrosis factor alpha (TNF-&#945;) (<xref rid="B76" ref-type="bibr">76</xref>), suggesting an involvement of EVs with atopic eczema (<xref rid="B76" ref-type="bibr">76</xref>). Oliveira and colleagues showed that <italic toggle="yes">C.&#160;neoformans</italic> EVs are biologically active <italic toggle="yes">in vitro</italic> (<xref rid="B77" ref-type="bibr">77</xref>): they stimulate nitric oxide, cytokine (TNF-&#945;, IL-10, and transforming growth factor &#946; [TGF-&#946;]), and fungicidal activity in macrophages (<xref rid="B77" ref-type="bibr">77</xref>). This observation might be related to the detection of key immunogens in <italic toggle="yes">C.&#160;neoformans</italic> EVs, including heat-shock proteins and GlcCer (<xref rid="B78" ref-type="bibr">78</xref>). In fact, human antibodies against <italic toggle="yes">C.&#160;neoformans</italic> GlcCer were demonstrated to be fungistatic (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B78" ref-type="bibr">78</xref>). Similarly, <italic toggle="yes">P.&#160;brasiliensis</italic> EVs also stimulated cytokine production in macrophages (<xref rid="B14" ref-type="bibr">14</xref>).</p><p>Although some reports suggest a protective role of <italic toggle="yes">C.&#160;neoformans</italic> EVs, other reports indicate that these compartments can enhance pathogenesis of this fungus. Huang and colleagues have demonstrated that <italic toggle="yes">C.&#160;neoformans</italic> EVs are able to cross the brain-blood barrier and accumulate in lesion sites of brain infection (<xref rid="B79" ref-type="bibr">79</xref>). In an <italic toggle="yes">in vitro</italic> model of <italic toggle="yes">C.&#160;neoformans</italic> infection, EVs facilitated adhesion and transcytosis of <italic toggle="yes">C.&#160;neoformans</italic> during interaction with human brain microvascular endothelial cells (<xref rid="B79" ref-type="bibr">79</xref>), leading to increased brain infectivity. Finally, pretreatment of mice with <italic toggle="yes">C.&#160;neoformans</italic> EVs rendered the mice more susceptible to cryptococcosis (<xref rid="B79" ref-type="bibr">79</xref>). Therefore, it is still unclear how <italic toggle="yes">C.&#160;neoformans</italic> EVs interfere with either fungal virulence or host stimulation.</p><p>There are no fungal vaccines in the clinic, although some animal studies suggest that a fungal vaccine in the clinic may be closer than ever. Wormley and colleagues have suggested the potential protection of using a gamma interferon (IFN-&#947;)-producing <italic toggle="yes">C.&#160;neoformans</italic> strain in a mouse pulmonary infection model (<xref rid="B80" ref-type="bibr">80</xref>). Mice were able to resolve the primary infection and showed complete protection against second pulmonary challenge with the <italic toggle="yes">C.&#160;neoformans</italic> strain (<xref rid="B80" ref-type="bibr">80</xref>). This finding, which was based on utilization of engineered fungi to produce host cytokines in order to induce a protective host immune response, was an important advance in the vaccine field. Another example of a potential fungal vaccine is the <italic toggle="yes">C.&#160;neoformans</italic> knockout strain lacking sterylglucosidase 1 (Sgl1), an enzyme responsible for degradation of sterylglucosides. The <italic toggle="yes">&#916;sgl1</italic> strain was nonpathogenic in an infection model and, interestingly, acted as a vaccine strain, protecting mice when administered prior to challenge with wild-type <italic toggle="yes">C.&#160;neoformans</italic> or <italic toggle="yes">C.&#160;gattii</italic> (<xref rid="B81" ref-type="bibr">81</xref>). This protection may be ascribed to a dramatic accumulation of sterol glucosides (SGs) in the <italic toggle="yes">&#916;sgl1</italic> mutant (<xref rid="B81" ref-type="bibr">81</xref>), and these fungal SGs may act as stronger immunostimulators than plant SGs (<xref rid="B82" ref-type="bibr">82</xref><xref ref-type="bibr" rid="B83">&#8211;</xref><xref rid="B85" ref-type="bibr">85</xref>). The most interesting observation was that the host was protected against primary and secondary infection even when CD4<sup>+</sup> T cells were deficient. These data suggest the potential protective effect of an attenuated fungal strain in immunodeficient hosts, such as HIV-positive patients, where cryptococcosis most frequently occurs. Interestingly, if SGs are found in the vesicles of the <italic toggle="yes">&#916;sgl1</italic> strain, this not only might significantly contribute to the protective effect but also could increase interest in using EVs instead of the live attenuated mutant as a vaccine formulation.</p><p>Recently, Vargas and colleagues demonstrated that EVs obtained from <italic toggle="yes">C.&#160;albicans</italic> cultures are immunologically active (<xref rid="B13" ref-type="bibr">13</xref>). Exposure of macrophages and dendritic cells to purified EVs resulted in nitric oxide production and release of IL-12, TGF-&#946;, and IL-10 in macrophages and of IL-10 and TNF-&#945; in dendritic cells (<xref rid="B13" ref-type="bibr">13</xref>). The ability of <italic toggle="yes">C.&#160;albicans</italic> EVs to stimulate host cells depended on lipid composition, since EVs from phospholipid synthase mutants differentially stimulated cytokine production in macrophages (<xref rid="B65" ref-type="bibr">65</xref>). Treatment of <italic toggle="yes">Galleria mellonella</italic> with EVs before infection with <italic toggle="yes">C.&#160;albicans</italic> reduced fungal burden (<xref rid="B13" ref-type="bibr">13</xref>). These data indicate the ability of <italic toggle="yes">C.&#160;albicans</italic> EVs to modulate the innate immune response and the potential of EVs to interfere with fungal pathogenesis <italic toggle="yes">in vivo</italic> in favor of infection control (<xref rid="B13" ref-type="bibr">13</xref>). Together, these results strongly suggest that fungal EVs activate host immunity by multiple mechanisms that may favor the host during fungal infections, reinforcing their potential use as a vaccination strategy.</p></sec><sec sec-type="conclusions" id="h7"><title>CONCLUSION</title><p>Fungal diseases are a global public health problem, especially for immunocompromised individuals, such as those affected by HIV infection and cancer (<xref rid="B86" ref-type="bibr">86</xref>) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cdc.gov/fungal/global/index.html">http://www.cdc.gov/fungal/global/index.html</ext-link>). It is estimated that millions of people die every year due to invasive fungal infection (<xref rid="B86" ref-type="bibr">86</xref><xref ref-type="bibr" rid="B87">&#8211;</xref><xref rid="B88" ref-type="bibr">88</xref>), with a mortality rate comparable to that of malaria (<xref rid="B89" ref-type="bibr">89</xref>). The current available antifungal therapies have significant disadvantages: polyene are toxic, azoles induce the development of resistance and are notorious for drug-drug interactions, and echinocandins have a narrow spectrum of activity (<xref rid="B86" ref-type="bibr">86</xref>, <xref rid="B90" ref-type="bibr">90</xref>). Thus, there is a need for research and development (R&amp;D) of new antifungals as well as new, alternative preventive strategies to combat fungal diseases.</p><p>As discussed above, fungal EVs may represent this new, alternative strategy once we fully understand their cargo and their role as virulence bags. Although there are a variety of examples of the role of fungal EVs in carrying many virulence factors, the relevance of their cargo <italic toggle="yes">in vivo</italic> is incompletely understood. On the other hand, fungal EVs are promising <italic toggle="yes">in vitro</italic> activators of the host immune system against pathogens that operate by inducing cytokine release by innate immune cells, suggesting that they may be a potent tool for vaccine development. Nevertheless, their role in <italic toggle="yes">in vivo</italic> protection is still under study. In bacteria, exciting results that have shown some examples of successful EV vaccines support the idea that fungal EVs could also be used as a protective tool against the most deadly fungal infections. In addition, the concept of therapeutic fungal vaccines is gaining more traction, since there are currently fungal proteins in preclinical phase I studies for vaccine development (<xref rid="B91" ref-type="bibr">91</xref>, <xref rid="B92" ref-type="bibr">92</xref>). More studies and more effort are clearly necessary for assessing the role of fungal EVs in the fungus-host interaction and to decipher the mechanisms by which they might stimulate a protective host response.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>This work was supported by grants from Brazilian agencies <funding-source id="gs1">Conselho Nacional de Desenvolvimento Cient&#237;fico e Tecnol&#243;gico (CNPq)</funding-source> and <funding-source id="gs2">Funda&#231;&#227;o de Amparo</funding-source> &#224; Pesquisa do Estado do Rio de Janeiro (<funding-source id="gs3">FAPERJ</funding-source>), by <funding-source id="gs4">NIH</funding-source> grants <award-id rid="gs4">AI56168</award-id>, <award-id rid="gs4">AI100631</award-id>, and <award-id rid="gs4">AI116420</award-id>, and by Merit Review grant <award-id rid="gs5">I01BX002624</award-id> from the <funding-source id="gs5">Veterans Affairs Program in Biomedical Laboratory Research and Development</funding-source> to M.D.P. M.D.P. is a Burroughs Wellcome Investigator in Infectious Diseases. M.L.R. also acknowledges support from the <funding-source id="gs6">Instituto Nacional de Ci&#234;ncia e Tecnologia de Inova&#231;&#227;o em Doen&#231;as Negligenciadas (INCT-IDN)</funding-source>. <funding-source id="gs7">M.L.R.</funding-source> is the recipient of a <award-id rid="gs8">Pathfinder Award</award-id> from the <funding-source id="gs8">Wellcome Trust</funding-source> (United Kingdom; grant no. <award-id>WT103212MF</award-id>).</p><p>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p><p>We are very grateful to Rodrigo Pinheiro and Arielle Bryan for valuable suggestions and English proofreading.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deatherage</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Cookson</surname><given-names>BT</given-names></name></person-group><year>2012</year><article-title>Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life</article-title>. <source>Infect Immun</source><volume>80</volume>:<fpage>1948</fpage>&#8211;<lpage>1957</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.06014-11</pub-id>.<pub-id pub-id-type="pmid">22409932</pub-id><pub-id pub-id-type="pmcid">PMC3370574</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodrigues</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Nimrichter</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Oliveira</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Frases</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Miranda</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Zaragoza</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Alvarez</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nakouzi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Feldmesser</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name></person-group><year>2007</year><article-title>Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport</article-title>. <source>Eukaryot Cell</source><volume>6</volume>:<fpage>48</fpage>&#8211;<lpage>59</lpage>. doi:<pub-id pub-id-type="doi">10.1128/EC.00318-06</pub-id>.<pub-id pub-id-type="pmid">17114598</pub-id><pub-id pub-id-type="pmcid">PMC1800364</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ellen</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Zolghadr</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Driessen</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Albers</surname><given-names>SV</given-names></name></person-group><year>2010</year><article-title>Shaping the archaeal cell envelope</article-title>. <source>Archaea</source><volume>2010</volume>:<fpage>608243</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2010/608243</pub-id>.<pub-id pub-id-type="pmid">20671907</pub-id><pub-id pub-id-type="pmcid">PMC2910488</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gho</surname><given-names>YS</given-names></name></person-group><year>2015</year><article-title>Gram-negative and Gram-positive bacterial extracellular vesicles</article-title>. <source>Semin Cell Dev Biol</source><volume>40</volume>:<fpage>97</fpage>&#8211;<lpage>104</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.semcdb.2015.02.006</pub-id>.<pub-id pub-id-type="pmid">25704309</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marcilla</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Martin-Jaular</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Trelis</surname><given-names>M</given-names></name>, <name name-style="western"><surname>de Menezes-Neto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Osuna</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bernal</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Fernandez-Becerra</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Del Portillo</surname><given-names>HA</given-names></name></person-group><year>2014</year><article-title>Extracellular vesicles in parasitic diseases</article-title>. <source>J Extracell Vesicles</source><volume>3</volume>:<fpage>25040</fpage>. doi:<pub-id pub-id-type="doi">10.3402/jev.v3.25040</pub-id>.<pub-id pub-id-type="pmid">25536932</pub-id><pub-id pub-id-type="pmcid">PMC4275648</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yanez-Mo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Siljander</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Andreu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zavec</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Borras</surname><given-names>FE</given-names></name>, <name name-style="western"><surname>Buzas</surname><given-names>EI</given-names></name>, <name name-style="western"><surname>Buzas</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Casal</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cappello</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Carvalho</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Colas</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cordeiro-da Silva</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fais</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Falcon-Perez</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Ghobrial</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Giebel</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Gimona</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Graner</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gursel</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Gursel</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Heegaard</surname><given-names>NH</given-names></name>, <name name-style="western"><surname>Hendrix</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kierulf</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kokubun</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kosanovic</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kralj-Iglic</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Kramer-Albers</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Laitinen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lasser</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lener</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ligeti</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Line</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lipps</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Llorente</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lotvall</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mancek-Keber</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Marcilla</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mittelbrunn</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nazarenko</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Nolte-'t Hoen</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Nyman</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>O'Driscoll</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Olivan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Oliveira</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pallinger</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Del Portillo</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Reventos</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rigau</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rohde</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sammar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sanchez-Madrid</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Santarem</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Schallmoser</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ostenfeld</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Stoorvogel</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Stukelj</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Van der Grein</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Vasconcelos</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Wauben</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>De Wever</surname><given-names>O</given-names></name></person-group><year>2015</year><article-title>Biological properties of extracellular vesicles and their physiological functions</article-title>. <source>J Extracell Vesicles</source><volume>4</volume>:<fpage>27066</fpage>.<pub-id pub-id-type="pmid">25979354</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3402/jev.v4.27066</pub-id><pub-id pub-id-type="pmcid">PMC4433489</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schorey</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>VL</given-names></name></person-group><year>2015</year><article-title>Exosomes and other extracellular vesicles in host-pathogen interactions</article-title>. <source>EMBO Rep</source><volume>16</volume>:<fpage>24</fpage>&#8211;<lpage>43</lpage>. doi:<pub-id pub-id-type="doi">10.15252/embr.201439363</pub-id>.<pub-id pub-id-type="pmid">25488940</pub-id><pub-id pub-id-type="pmcid">PMC4304727</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Th&#233;ry</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ostrowski</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Segura</surname><given-names>E</given-names></name></person-group><year>2009</year><article-title>Membrane vesicles as conveyors of immune responses</article-title>. <source>Nat Rev Immunol</source><volume>9</volume>:<fpage>581</fpage>&#8211;<lpage>593</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nri2567</pub-id>.<pub-id pub-id-type="pmid">19498381</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Prados-Rosales</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name></person-group><year>2015</year><article-title>Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi</article-title>. <source>Nat Rev Microbiol</source><volume>13</volume>:<fpage>620</fpage>&#8211;<lpage>630</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro3480</pub-id>.<pub-id pub-id-type="pmid">26324094</pub-id><pub-id pub-id-type="pmcid">PMC4860279</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodrigues</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Godinho</surname><given-names>RMC</given-names></name>, <name name-style="western"><surname>Zamith-Miranda</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Nimrichter</surname><given-names>L</given-names></name></person-group><year>2015</year><article-title>Traveling into outer space: unanswered questions about fungal extracellular vesicles</article-title>. <source>PLoS Pathog</source><volume>11</volume>:<fpage>e1005240</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1005240</pub-id>.<pub-id pub-id-type="pmid">26633018</pub-id><pub-id pub-id-type="pmcid">PMC4669077</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kulp</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kuehn</surname><given-names>MJ</given-names></name></person-group><year>2010</year><article-title>Biological functions and biogenesis of secreted bacterial outer membrane vesicles</article-title>. <source>Annu Rev Microbiol</source><volume>64</volume>:<fpage>163</fpage>&#8211;<lpage>184</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.micro.091208.073413</pub-id>.<pub-id pub-id-type="pmid">20825345</pub-id><pub-id pub-id-type="pmcid">PMC3525469</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rivera</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cordero</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Nakouzi</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Frases</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nicola</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name></person-group><year>2010</year><article-title>Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>107</volume>:<fpage>19002</fpage>&#8211;<lpage>19007</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1008843107</pub-id>.<pub-id pub-id-type="pmid">20956325</pub-id><pub-id pub-id-type="pmcid">PMC2973860</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vargas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rocha</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Oliveira</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Albuquerque</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Frases</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Santos</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Nosanchuk</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Gomes</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Medeiros</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Miranda</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sobreira</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Nakayasu</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Arigi</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Guimaraes</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Rodrigues</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Freire-de-Lima</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Nimrichter</surname><given-names>L</given-names></name></person-group><year>2015</year><article-title>Compositional and immunobiological analyses of extracellular vesicles released by Candida albicans</article-title>. <source>Cell Microbiol</source><volume>17</volume>:<fpage>389</fpage>&#8211;<lpage>407</lpage>. doi:<pub-id pub-id-type="doi">10.1111/cmi.12374</pub-id>.<pub-id pub-id-type="pmid">25287304</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peres da Silva</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Heiss</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Black</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Azadi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gerlach</surname><given-names>JQ</given-names></name>, <name name-style="western"><surname>Travassos</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Joshi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kilcoyne</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Puccia</surname><given-names>R</given-names></name></person-group><year>2015</year><article-title>Extracellular vesicles from Paracoccidioides pathogenic species transport polysaccharide and expose ligands for DC-SIGN receptors</article-title>. <source>Sci Rep</source><volume>5</volume>:<fpage>14213</fpage>. doi:<pub-id pub-id-type="doi">10.1038/srep14213</pub-id>.<pub-id pub-id-type="pmid">26387503</pub-id><pub-id pub-id-type="pmcid">PMC4585699</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bishop</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Work</surname><given-names>E</given-names></name></person-group><year>1965</year><article-title>An extracellular glycolipid produced by Escherichia coli grown under lysine-limiting conditions</article-title>. <source>Biochem J</source><volume>96</volume>:<fpage>567</fpage>&#8211;<lpage>576</lpage>. doi:<pub-id pub-id-type="doi">10.1042/bj0960567</pub-id>.<pub-id pub-id-type="pmid">4953781</pub-id><pub-id pub-id-type="pmcid">PMC1207076</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Work</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Knox</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Vesk</surname><given-names>M</given-names></name></person-group><year>1966</year><article-title>The chemistry and electron microscopy of an extracellular lipopolysaccharide from <italic toggle="yes">Escherichia coli</italic></article-title>. <source>Ann N Y Acad Sci</source><volume>133</volume>:<fpage>438</fpage>&#8211;<lpage>449</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1749-6632.1966.tb52382.x</pub-id>.<pub-id pub-id-type="pmid">5336349</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knox</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Vesk</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Work</surname><given-names>E</given-names></name></person-group><year>1966</year><article-title>Relation between excreted lipopolysaccharide complexes and surface structures of a lysine-limited culture of <italic toggle="yes">Escherichia coli</italic></article-title>. <source>J Bacteriol</source><volume>92</volume>:<fpage>1206</fpage>&#8211;<lpage>1217</lpage>.<pub-id pub-id-type="pmid">4959044</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jb.92.4.1206-1217.1966</pub-id><pub-id pub-id-type="pmcid">PMC276396</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knox</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Cullen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Work</surname><given-names>E</given-names></name></person-group><year>1967</year><article-title>An extracellular lipopolysaccharide-phospholipid-protein complex produced by <italic toggle="yes">Escherichia coli</italic> grown under lysine-limiting conditions</article-title>. <source>Biochem J</source><volume>103</volume>:<fpage>192</fpage>&#8211;<lpage>201</lpage>. doi:<pub-id pub-id-type="doi">10.1042/bj1030192</pub-id>.<pub-id pub-id-type="pmid">5340506</pub-id><pub-id pub-id-type="pmcid">PMC1270384</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwechheimer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kuehn</surname><given-names>MJ</given-names></name></person-group><year>2015</year><article-title>Outer-membrane vesicles from gram-negative bacteria: biogenesis and functions</article-title>. <source>Nat Rev Microbiol</source><volume>13</volume>:<fpage>605</fpage>&#8211;<lpage>619</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro3525</pub-id>.<pub-id pub-id-type="pmid">26373371</pub-id><pub-id pub-id-type="pmcid">PMC5308417</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Acevedo</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Fern&#225;ndez</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zayas</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Acosta</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sarmiento</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Ferro</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Rosenqvist</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Campa</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cardoso</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Garcia</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Perez</surname><given-names>JL</given-names></name></person-group><year>2014</year><article-title>Bacterial outer membrane vesicles and vaccine applications</article-title>. <source>Front Immunol</source><volume>5</volume>:<fpage>121</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2014.00121</pub-id>.<pub-id pub-id-type="pmid">24715891</pub-id><pub-id pub-id-type="pmcid">PMC3970029</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>HI</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Gho</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Jeon</surname><given-names>SG</given-names></name></person-group><year>2015</year><article-title>Vaccination with Klebsiella pneumoniae-derived extracellular vesicles protects against bacteria-induced lethality via both humoral and cellular immunity</article-title>. <source>Exp Mol Med</source><volume>47</volume>:<fpage>e183</fpage>. doi:<pub-id pub-id-type="doi">10.1038/emm.2015.59</pub-id>.<pub-id pub-id-type="pmid">26358222</pub-id><pub-id pub-id-type="pmcid">PMC4650931</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnold</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Galloway</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>McNicholas</surname><given-names>A</given-names></name>, <name name-style="western"><surname>O&#8217;Hallahan</surname><given-names>J</given-names></name></person-group><year>2011</year><article-title>Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand</article-title>. <source>Vaccine</source><volume>29</volume>:<fpage>7100</fpage>&#8211;<lpage>7106</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2011.06.120</pub-id>.<pub-id pub-id-type="pmid">21803101</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holst</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Oster</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Arnold</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Tatley</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>N&#230;ss</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Aaberge</surname><given-names>IS</given-names></name>, <name name-style="western"><surname>Galloway</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>McNicholas</surname><given-names>A</given-names></name>, <name name-style="western"><surname>O&#8217;Hallahan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rosenqvist</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Black</surname><given-names>S</given-names></name></person-group><year>2013</year><article-title>Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future</article-title>. <source>Hum Vaccin Immunother</source><volume>9</volume>:<fpage>1241</fpage>&#8211;<lpage>1253</lpage>. doi:<pub-id pub-id-type="doi">10.4161/hv.24129</pub-id>.<pub-id pub-id-type="pmid">23857274</pub-id><pub-id pub-id-type="pmcid">PMC3901813</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shockman</surname><given-names>GD</given-names></name>, <name name-style="western"><surname>Barren</surname><given-names>JF</given-names></name></person-group><year>1983</year><article-title>Structure, function, and assembly of cell walls of gram-positive bacteria</article-title>. <source>Annu Rev Microbiol</source><volume>37</volume>:<fpage>501</fpage>&#8211;<lpage>527</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.mi.37.100183.002441</pub-id>.<pub-id pub-id-type="pmid">6139058</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Go</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Gho</surname><given-names>YS</given-names></name></person-group><year>2015</year><article-title>Proteomic analysis of extracellular vesicles derived from Mycobacterium tuberculosis</article-title>. <source>Proteomics</source><volume>15</volume>:<fpage>3331</fpage>&#8211;<lpage>3337</lpage>. doi:<pub-id pub-id-type="doi">10.1002/pmic.201500037</pub-id>.<pub-id pub-id-type="pmid">26201501</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olaya-Abril</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Prados-Rosales</surname><given-names>R</given-names></name>, <name name-style="western"><surname>McConnell</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Mart&#237;n-Pe&#241;a</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gonz&#225;lez-Reyes</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Jim&#233;nez-Mungu&#237;a</surname><given-names>I</given-names></name>, <name name-style="western"><surname>G&#243;mez-Gasc&#243;n</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Fern&#225;ndez</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Luque-Garc&#237;a</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Garc&#237;a-Lid&#243;n</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Est&#233;vez</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Pach&#243;n</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Obando</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pirofski</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Rodr&#237;guez-Ortega</surname><given-names>MJ</given-names></name></person-group><year>2014</year><article-title>Characterization of protective extracellular membrane-derived vesicles produced by Streptococcus pneumoniae</article-title>. <source>J Proteomics</source><volume>106</volume>:<fpage>46</fpage>&#8211;<lpage>60</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jprot.2014.04.023</pub-id>.<pub-id pub-id-type="pmid">24769240</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scheurwater</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Burrows</surname><given-names>LL</given-names></name></person-group><year>2011</year><article-title>Maintaining network security: how macromolecular structures cross the peptidoglycan layer</article-title>. <source>FEMS Microbiol Lett</source><volume>318</volume>:<fpage>1</fpage>&#8211;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1574-6968.2011.02228.x</pub-id>.<pub-id pub-id-type="pmid">21276045</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>EY</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>DY</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>JO</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Desiderio</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>YK</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>KP</given-names></name>, <name name-style="western"><surname>Gho</surname><given-names>YS</given-names></name></person-group><year>2009</year><article-title>Gram-positive bacteria produce membrane vesicles: proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles</article-title>. <source>Proteomics</source><volume>9</volume>:<fpage>5425</fpage>&#8211;<lpage>5436</lpage>. doi:<pub-id pub-id-type="doi">10.1002/pmic.200900338</pub-id>.<pub-id pub-id-type="pmid">19834908</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kessler</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cabezas-Sanchez</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Luque-Garcia</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name></person-group><year>2014</year><article-title>Extracellular vesicles produced by the Gram-positive bacterium Bacillus subtilis are disrupted by the lipopeptide surfactin</article-title>. <source>Mol Microbiol</source><volume>93</volume>:<fpage>183</fpage>&#8211;<lpage>198</lpage>. doi:<pub-id pub-id-type="doi">10.1111/mmi.12650</pub-id>.<pub-id pub-id-type="pmid">24826903</pub-id><pub-id pub-id-type="pmcid">PMC4079059</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>JH</given-names></name></person-group><year>2013</year><article-title>Transcription factor sigmaB plays an important role in the production of extracellular membrane-derived vesicles in Listeria monocytogenes</article-title>. <source>PLoS One</source><volume>8</volume>:<fpage>e73196</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0073196</pub-id>.<pub-id pub-id-type="pmid">23977379</pub-id><pub-id pub-id-type="pmcid">PMC3748028</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>EY</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>KP</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>YK</given-names></name>, <name name-style="western"><surname>Roh</surname><given-names>TY</given-names></name>, <name name-style="western"><surname>Gho</surname><given-names>YS</given-names></name></person-group><year>2013</year><article-title>Staphylococcus aureus extracellular vesicles carry biologically active beta-lactamase</article-title>. <source>Antimicrob Agents Chemother</source><volume>57</volume>:<fpage>2589</fpage>&#8211;<lpage>2595</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.00522-12</pub-id>.<pub-id pub-id-type="pmid">23529736</pub-id><pub-id pub-id-type="pmcid">PMC3716153</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prados-Rosales</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Carre&#241;o</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Batista-Gonzalez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Baena</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Venkataswamy</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Wallstrom</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Magee</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>LaBaer</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Achkar</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr.</suffix></name>, <name name-style="western"><surname>Chan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Porcelli</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name></person-group><year>2014</year><article-title>Mycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of <italic toggle="yes">Mycobacterium tuberculosis</italic></article-title>. <source>mBio</source><volume>5</volume>:<comment>e01921-14</comment>. doi:<pub-id pub-id-type="doi">10.1128/mBio.01921-14</pub-id>.<pub-id pub-id-type="pmcid">PMC4196239</pub-id><pub-id pub-id-type="pmid">25271291</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Torrecilhas</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Schumacher</surname><given-names>RI</given-names></name>, <name name-style="western"><surname>Alves</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Colli</surname><given-names>W</given-names></name></person-group><year>2012</year><article-title>Vesicles as carriers of virulence factors in parasitic protozoan diseases</article-title>. <source>Microbes Infect</source><volume>14</volume>:<fpage>1465</fpage>&#8211;<lpage>1474</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.micinf.2012.07.008</pub-id>.<pub-id pub-id-type="pmid">22892602</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trocoli Torrecilhas</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Tonelli</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Pavanelli</surname><given-names>WR</given-names></name>, <name name-style="western"><surname>da Silva</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Schumacher</surname><given-names>RI</given-names></name>, <name name-style="western"><surname>de Souza</surname><given-names>W</given-names></name>, <name name-style="western"><surname>E Silva</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>de Almeida Abrahamsohn</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Colli</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Manso Alves</surname><given-names>MJ</given-names></name></person-group><year>2009</year><article-title>Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response</article-title>. <source>Microbes Infect</source><volume>11</volume>:<fpage>29</fpage>&#8211;<lpage>39</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.micinf.2008.10.003</pub-id>.<pub-id pub-id-type="pmid">19028594</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silverman</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Clos</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Horakova</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>AY</given-names></name>, <name name-style="western"><surname>Wiesgigl</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kelly</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Lynn</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>McMaster</surname><given-names>WR</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Levings</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Reiner</surname><given-names>NE</given-names></name></person-group><year>2010</year><article-title>Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells</article-title>. <source>J Immunol</source><volume>185</volume>:<fpage>5011</fpage>&#8211;<lpage>5022</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.1000541</pub-id>.<pub-id pub-id-type="pmid">20881185</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gon&#231;alves</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Umezawa</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Katzin</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>de Souza</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Alves</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Zingales</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Colli</surname><given-names>W</given-names></name></person-group><year>1991</year><article-title>Trypanosoma cruzi: shedding of surface antigens as membrane vesicles</article-title>. <source>Exp Parasitol</source><volume>72</volume>:<fpage>43</fpage>&#8211;<lpage>53</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0014-4894(91)90119-H</pub-id>.<pub-id pub-id-type="pmid">1993464</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bayer-Santos</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Aguilar-Bonavides</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rodrigues</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Cordero</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Marques</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Varela-Ramirez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>N</given-names></name>, <name name-style="western"><surname>da Silveira</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>IC</given-names></name></person-group><year>2013</year><article-title>Proteomic analysis of Trypanosoma cruzi secretome: characterization of two populations of extracellular vesicles and soluble proteins</article-title>. <source>J Proteome Res</source><volume>12</volume>:<fpage>883</fpage>&#8211;<lpage>897</lpage>. doi:<pub-id pub-id-type="doi">10.1021/pr300947g</pub-id>.<pub-id pub-id-type="pmid">23214914</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bayer-Santos</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Lima</surname><given-names>FM</given-names></name>, <name name-style="western"><surname>Ruiz</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>da Silveira</surname><given-names>JF</given-names></name></person-group><year>2014</year><article-title>Characterization of the small RNA content of Trypanosoma cruzi extracellular vesicles</article-title>. <source>Mol Biochem Parasitol</source><volume>193</volume>:<fpage>71</fpage>&#8211;<lpage>74</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molbiopara.2014.02.004</pub-id>.<pub-id pub-id-type="pmid">24583081</pub-id><pub-id pub-id-type="pmcid">PMC4058860</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia-Silva</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>das Neves</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>Cabrera-Cabrera</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Sanguinetti</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Medeiros</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Robello</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Naya</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fernandez-Calero</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Souto-Padron</surname><given-names>T</given-names></name>, <name name-style="western"><surname>de Souza</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Cayota</surname><given-names>A</given-names></name></person-group><year>2014</year><article-title>Extracellular vesicles shed by Trypanosoma cruzi are linked to small RNA pathways, life cycle regulation, and susceptibility to infection of mammalian cells</article-title>. <source>Parasitol Res</source><volume>113</volume>:<fpage>285</fpage>&#8211;<lpage>304</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00436-013-3655-1</pub-id>.<pub-id pub-id-type="pmid">24241124</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Regev-Rudzki</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Carvalho</surname><given-names>TG</given-names></name>, <name name-style="western"><surname>Sisquella</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Coleman</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Rug</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bursac</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Angrisano</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Gee</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hill</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Baum</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cowman</surname><given-names>AF</given-names></name></person-group><year>2013</year><article-title>Cell-cell communication between malaria-infected red blood cells via exosome-like vesicles</article-title>. <source>Cell</source><volume>153</volume>:<fpage>1120</fpage>&#8211;<lpage>1133</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2013.04.029</pub-id>.<pub-id pub-id-type="pmid">23683579</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandez-Calero</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Garcia-Silva</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pena</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Robello</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Persson</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Rovira</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Naya</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Cayota</surname><given-names>A</given-names></name></person-group><year>2015</year><article-title>Profiling of small RNA cargo of extracellular vesicles shed by Trypanosoma cruzi reveals a specific extracellular signature</article-title>. <source>Mol Biochem Parasitol</source><volume>199</volume>:<fpage>19</fpage>&#8211;<lpage>28</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molbiopara.2015.03.003</pub-id>.<pub-id pub-id-type="pmid">25795082</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szempruch</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Sykes</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Kieft</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dennison</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Gartrell</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Nakayasu</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Hajduk</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Harrington</surname><given-names>JM</given-names></name></person-group><year>2016</year><article-title>Extracellular vesicles from Trypanosoma brucei Mediate virulence factor transfer and cause host anemia</article-title>. <source>Cell</source><volume>164</volume>:<fpage>246</fpage>&#8211;<lpage>257</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2015.11.051</pub-id>.<pub-id pub-id-type="pmid">26771494</pub-id><pub-id pub-id-type="pmcid">PMC4715261</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolf</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Espadas-Moreno</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Luque-Garcia</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name></person-group><year>2014</year><article-title>Interaction of Cryptococcus neoformans extracellular vesicles with the cell wall</article-title>. <source>Eukaryot Cell</source><volume>13</volume>:<fpage>1484</fpage>&#8211;<lpage>1493</lpage>. doi:<pub-id pub-id-type="doi">10.1128/EC.00111-14</pub-id>.<pub-id pub-id-type="pmid">24906412</pub-id><pub-id pub-id-type="pmcid">PMC4248683</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodrigues</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Franzen</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Nimrichter</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Miranda</surname><given-names>K</given-names></name></person-group><year>2013</year><article-title>Vesicular mechanisms of traffic of fungal molecules to the extracellular space</article-title>. <source>Curr Opin Microbiol</source><volume>16</volume>:<fpage>414</fpage>&#8211;<lpage>420</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mib.2013.04.002</pub-id>.<pub-id pub-id-type="pmid">23628115</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodrigues</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Travassos</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Miranda</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Franzen</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Rozental</surname><given-names>S</given-names></name>, <name name-style="western"><surname>de Souza</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Alviano</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Barreto-Bergter</surname><given-names>E</given-names></name></person-group><year>2000</year><article-title>Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth</article-title>. <source>Infect Immun</source><volume>68</volume>:<fpage>7049</fpage>&#8211;<lpage>7060</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.68.12.7049-7060.2000</pub-id>.<pub-id pub-id-type="pmid">11083830</pub-id><pub-id pub-id-type="pmcid">PMC97815</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Nakayasu</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Joffe</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Guimar&#227;es</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Sobreira</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Nosanchuk</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Cordero</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Frases</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Nimrichter</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Rodrigues</surname><given-names>ML</given-names></name></person-group><year>2010</year><article-title>Characterization of yeast extracellular vesicles: evidence for the participation of different pathways of cellular traffic in vesicle biogenesis</article-title>. <source>PLoS One</source><volume>5</volume>:<fpage>e11113</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0011113</pub-id>.<pub-id pub-id-type="pmid">20559436</pub-id><pub-id pub-id-type="pmcid">PMC2885426</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albuquerque</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Nakayasu</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Rodrigues</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Frases</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zancope-Oliveira</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Nosanchuk</surname><given-names>JD</given-names></name></person-group><year>2008</year><article-title>Vesicular transport in Histoplasma capsulatum: an effective mechanism for trans-cell wall transfer of proteins and lipids in ascomycetes</article-title>. <source>Cell Microbiol</source><volume>10</volume>:<fpage>1695</fpage>&#8211;<lpage>1710</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1462-5822.2008.01160.x</pub-id>.<pub-id pub-id-type="pmid">18419773</pub-id><pub-id pub-id-type="pmcid">PMC2562661</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodrigues</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Nimrichter</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Oliveira</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Nosanchuk</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name></person-group><year>2008</year><article-title>Vesicular trans-cell Wall transport in fungi: A mechanism for the Delivery of virulence-associated macromolecules?</article-title><source>Lipid Insights</source><volume>2</volume>:<fpage>27</fpage>&#8211;<lpage>40</lpage>.<pub-id pub-id-type="pmid">20617119</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4137/lpi.s1000</pub-id><pub-id pub-id-type="pmcid">PMC2898286</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vallejo</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Nakayasu</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Matsuo</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Sobreira</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Longo</surname><given-names>LV</given-names></name>, <name name-style="western"><surname>Ganiko</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Puccia</surname><given-names>R</given-names></name></person-group><year>2012</year><article-title>Vesicle and vesicle-free extracellular proteome of Paracoccidioides brasiliensis: comparative analysis with other pathogenic fungi</article-title>. <source>J Proteome Res</source><volume>11</volume>:<fpage>1676</fpage>&#8211;<lpage>1685</lpage>. doi:<pub-id pub-id-type="doi">10.1021/pr200872s</pub-id>.<pub-id pub-id-type="pmid">22288420</pub-id><pub-id pub-id-type="pmcid">PMC3319080</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vallejo</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Matsuo</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Ganiko</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Medeiros</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Miranda</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Silva</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Freym&#252;ller-Haapalainen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sinigaglia-Coimbra</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Puccia</surname><given-names>R</given-names></name></person-group><year>2011</year><article-title>The pathogenic fungus Paracoccidioides brasiliensis exports extracellular vesicles containing highly immunogenic alpha-galactosyl epitopes</article-title>. <source>Eukaryot Cell</source><volume>10</volume>:<fpage>343</fpage>&#8211;<lpage>351</lpage>. doi:<pub-id pub-id-type="doi">10.1128/EC.00227-10</pub-id>.<pub-id pub-id-type="pmid">21216942</pub-id><pub-id pub-id-type="pmcid">PMC3067469</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peres da Silva</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Puccia</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Rodrigues</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Oliveira</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Joffe</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>C&#233;sar</surname><given-names>GV</given-names></name>, <name name-style="western"><surname>Nimrichter</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Goldenberg</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Alves</surname><given-names>LR</given-names></name></person-group><year>2015</year><article-title>Extracellular vesicle-mediated export of fungal RNA</article-title>. <source>Sci Rep</source><volume>5</volume>:<fpage>7763</fpage>. doi:<pub-id pub-id-type="doi">10.1038/srep07763</pub-id>.<pub-id pub-id-type="pmid">25586039</pub-id><pub-id pub-id-type="pmcid">PMC5379013</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eisenman</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Frases</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nicola</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Rodrigues</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name></person-group><year>2009</year><article-title>Vesicle-associated melanization in Cryptococcus neoformans</article-title>. <source>Microbiology</source><volume>155</volume>:<fpage>3860</fpage>&#8211;<lpage>3867</lpage>. doi:<pub-id pub-id-type="doi">10.1099/mic.0.032854-0</pub-id>.<pub-id pub-id-type="pmid">19729402</pub-id><pub-id pub-id-type="pmcid">PMC2889422</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vallejo</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Nakayasu</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Longo</surname><given-names>LV</given-names></name>, <name name-style="western"><surname>Ganiko</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lopes</surname><given-names>FG</given-names></name>, <name name-style="western"><surname>Matsuo</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Puccia</surname><given-names>R</given-names></name></person-group><year>2012</year><article-title>Lipidomic analysis of extracellular vesicles from the pathogenic phase of Paracoccidioides brasiliensis</article-title>. <source>PLoS One</source><volume>7</volume>:<fpage>e39463</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0039463</pub-id>.<pub-id pub-id-type="pmid">22745761</pub-id><pub-id pub-id-type="pmcid">PMC3382159</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rittershaus</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Kechichian</surname><given-names>TB</given-names></name>, <name name-style="western"><surname>Allegood</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Merrill</surname><given-names>AH</given-names><suffix>Jr.</suffix></name>, <name name-style="western"><surname>Hennig</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Luberto</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Del Poeta</surname><given-names>M</given-names></name></person-group><year>2006</year><article-title>Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans</article-title>. <source>J Clin Invest</source><volume>116</volume>:<fpage>1651</fpage>&#8211;<lpage>1659</lpage>. doi:<pub-id pub-id-type="doi">10.1172/JCI27890</pub-id>.<pub-id pub-id-type="pmid">16741577</pub-id><pub-id pub-id-type="pmcid">PMC1466548</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noble</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>French</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kohn</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>AD</given-names></name></person-group><year>2010</year><article-title>Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity</article-title>. <source>Nat Genet</source><volume>42</volume>:<fpage>590</fpage>&#8211;<lpage>598</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.605</pub-id>.<pub-id pub-id-type="pmid">20543849</pub-id><pub-id pub-id-type="pmcid">PMC2893244</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rittenour</surname><given-names>WR</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cahoon</surname><given-names>EB</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>SD</given-names></name></person-group><year>2011</year><article-title>Control of glucosylceramide production and morphogenesis by the Bar1 ceramide synthase in Fusarium graminearum</article-title>. <source>PLoS One</source><volume>6</volume>:<fpage>e19385</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0019385</pub-id>.<pub-id pub-id-type="pmid">21559419</pub-id><pub-id pub-id-type="pmcid">PMC3084840</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levery</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Momany</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lindsey</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Toledo</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Shayman</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Fuller</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Brooks</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Doong</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Straus</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>HK</given-names></name></person-group><year>2002</year><article-title>Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP-Glc:ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth</article-title>. <source>FEBS Lett</source><volume>525</volume>:<fpage>59</fpage>&#8211;<lpage>64</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0014-5793(02)03067-3</pub-id>.<pub-id pub-id-type="pmid">12163162</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia-Silva</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Cabrera-Cabrera</surname><given-names>F</given-names></name>, <name name-style="western"><surname>das Neves</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>Souto-Padr&#243;n</surname><given-names>T</given-names></name>, <name name-style="western"><surname>de Souza</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Cayota</surname><given-names>A</given-names></name></person-group><year>2014</year><article-title>Gene expression changes induced by Trypanosoma cruzi shed microvesicles in mammalian host cells: relevance of tRNA-derived halves</article-title>. <source>BioMed Res Int</source><volume>2014</volume>:<fpage>305239</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2014/305239</pub-id>.<pub-id pub-id-type="pmid">24812611</pub-id><pub-id pub-id-type="pmcid">PMC4000953</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cox</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Mukherjee</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cole</surname><given-names>GT</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Perfect</surname><given-names>JR</given-names></name></person-group><year>2000</year><article-title>Urease as a virulence factor in experimental cryptococcosis</article-title>. <source>Infect Immun</source><volume>68</volume>:<fpage>443</fpage>&#8211;<lpage>448</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.68.2.443-448.2000</pub-id>.<pub-id pub-id-type="pmid">10639402</pub-id><pub-id pub-id-type="pmcid">PMC97161</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnold</surname><given-names>WN</given-names></name>, <name name-style="western"><surname>Mann</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Sakai</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Garrison</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Coleman</surname><given-names>PD</given-names></name></person-group><year>1986</year><article-title>Acid phosphatases of Sporothrix schenckii</article-title>. <source>J Gen Microbiol</source><volume>132</volume>:<fpage>3421</fpage>&#8211;<lpage>3432</lpage>. doi:<pub-id pub-id-type="doi">10.1099/00221287-132-12-3421</pub-id>.<pub-id pub-id-type="pmid">3655720</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahvi</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Spicer</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>NJ</given-names></name></person-group><year>1974</year><article-title>Cytochemistry of acid mucosubstance and acid phosphatase in Cryptococcus neoformans</article-title>. <source>Can J Microbiol</source><volume>20</volume>:<fpage>833</fpage>&#8211;<lpage>838</lpage>. doi:<pub-id pub-id-type="doi">10.1139/m74-128</pub-id>.<pub-id pub-id-type="pmid">4134831</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernard</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mouyna</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Dubreucq</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Debeaupuis</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Fontaine</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Vorgias</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fuglsang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Latg&#233;</surname><given-names>JP</given-names></name></person-group><year>2002</year><article-title>Characterization of a cell-wall acid phosphatase (PhoAp) in Aspergillus fumigatus</article-title>. <source>Microbiology</source><volume>148</volume>:<fpage>2819</fpage>&#8211;<lpage>2829</lpage>. doi:<pub-id pub-id-type="doi">10.1099/00221287-148-9-2819</pub-id>.<pub-id pub-id-type="pmid">12213928</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panepinto</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Komperda</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Frases</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>YD</given-names></name>, <name name-style="western"><surname>Djordjevic</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Williamson</surname><given-names>PR</given-names></name></person-group><year>2009</year><article-title>Sec6-dependent sorting of fungal extracellular exosomes and laccase of Cryptococcus neoformans</article-title>. <source>Mol Microbiol</source><volume>71</volume>:<fpage>1165</fpage>&#8211;<lpage>1176</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2958.2008.06588.x</pub-id>.<pub-id pub-id-type="pmid">19210702</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoneda</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Doering</surname><given-names>TL</given-names></name></person-group><year>2006</year><article-title>A eukaryotic capsular polysaccharide is synthesized intracellularly and secreted via exocytosis</article-title>. <source>Mol Biol Cell</source><volume>17</volume>:<fpage>5131</fpage>&#8211;<lpage>5140</lpage>. doi:<pub-id pub-id-type="doi">10.1091/mbc.E06-08-0701</pub-id>.<pub-id pub-id-type="pmid">17021252</pub-id><pub-id pub-id-type="pmcid">PMC1679678</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolf</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Espadas</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Luque-Garcia</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Reynolds</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name></person-group><year>2015</year><article-title>Lipid biosynthetic genes affect Candida albicans extracellular vesicle morphology, Cargo, and immunostimulatory properties</article-title>. <source>Eukaryot Cell</source><volume>14</volume>:<fpage>745</fpage>&#8211;<lpage>754</lpage>. doi:<pub-id pub-id-type="doi">10.1128/EC.00054-15</pub-id>.<pub-id pub-id-type="pmid">26024904</pub-id><pub-id pub-id-type="pmcid">PMC4519749</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolf</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Rivera</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name></person-group><year>2012</year><article-title>Serum albumin disrupts Cryptococcus neoformans and Bacillus anthracis extracellular vesicles</article-title>. <source>Cell Microbiol</source><volume>14</volume>:<fpage>762</fpage>&#8211;<lpage>773</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1462-5822.2012.01757.x</pub-id>.<pub-id pub-id-type="pmid">22289081</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vader</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Breakefield</surname><given-names>XO</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>MJ</given-names></name></person-group><year>2014</year><article-title>Extracellular vesicles: emerging targets for cancer therapy</article-title>. <source>Trends Mol Med</source><volume>20</volume>:<fpage>385</fpage>&#8211;<lpage>393</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molmed.2014.03.002</pub-id>.<pub-id pub-id-type="pmid">24703619</pub-id><pub-id pub-id-type="pmcid">PMC4082760</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>N&#228;slund</surname><given-names>TI</given-names></name>, <name name-style="western"><surname>Gehrmann</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Gabrielsson</surname><given-names>S</given-names></name></person-group><year>2013</year><article-title>Cancer immunotherapy with exosomes requires B-cell activation</article-title>. <source>Oncoimmunology</source><volume>2</volume>:<fpage>e24533</fpage>. doi:<pub-id pub-id-type="doi">10.4161/onci.24533</pub-id>.<pub-id pub-id-type="pmid">23894715</pub-id><pub-id pub-id-type="pmcid">PMC3716750</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frasch</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>JD</given-names></name></person-group><year>1978</year><article-title>Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model</article-title>. <source>J Exp Med</source><volume>147</volume>:<fpage>629</fpage>&#8211;<lpage>644</lpage>. doi:<pub-id pub-id-type="doi">10.1084/jem.147.3.629</pub-id>.<pub-id pub-id-type="pmid">416164</pub-id><pub-id pub-id-type="pmcid">PMC2184206</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sierra</surname><given-names>GV</given-names></name>, <name name-style="western"><surname>Campa</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Varcacel</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Garcia</surname><given-names>IL</given-names></name>, <name name-style="western"><surname>Izquierdo</surname><given-names>PL</given-names></name>, <name name-style="western"><surname>Sotolongo</surname><given-names>PF</given-names></name>, <name name-style="western"><surname>Casanueva</surname><given-names>GV</given-names></name>, <name name-style="western"><surname>Rico</surname><given-names>CO</given-names></name>, <name name-style="western"><surname>Rodriguez</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Terry</surname><given-names>MH</given-names></name></person-group><year>1991</year><article-title>Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba</article-title>. <source>NIPH Ann</source><volume>14</volume>:<fpage>195</fpage>&#8211;<lpage>207</lpage>; discussion:<fpage>208</fpage>&#8211;<lpage>210</lpage>.<pub-id pub-id-type="pmid">1812432</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holst</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Arnold</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Huergo</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Oster</surname><given-names>P</given-names></name>, <name name-style="western"><surname>O&#8217;Hallahan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rosenqvist</surname><given-names>E</given-names></name></person-group><year>2009</year><article-title>Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis</article-title>. <source>Vaccine</source><volume>27</volume>(<issue>Suppl 2</issue>):<fpage>B3</fpage>&#8211;<lpage>12</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2009.04.071</pub-id>.<pub-id pub-id-type="pmid">19481313</pub-id></mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Findlow</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Borrow</surname><given-names>R</given-names></name></person-group><year>2011</year><article-title>Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles</article-title>. <source>Expert Opin Biol Ther</source><volume>11</volume>:<fpage>969</fpage>&#8211;<lpage>985</lpage>. doi:<pub-id pub-id-type="doi">10.1517/14712598.2011.585965</pub-id>.<pub-id pub-id-type="pmid">21615224</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenqvist</surname><given-names>E</given-names></name>, <name name-style="western"><surname>H&#248;iby</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Wedege</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bryn</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kolberg</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Klem</surname><given-names>A</given-names></name>, <name name-style="western"><surname>R&#248;nnild</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bjune</surname><given-names>G</given-names></name>, <name name-style="western"><surname>N&#248;kleby</surname><given-names>H</given-names></name></person-group><year>1995</year><article-title>Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine</article-title>. <source>Infect Immun</source><volume>63</volume>:<fpage>4642</fpage>&#8211;<lpage>4652</lpage>.<pub-id pub-id-type="pmid">7591118</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.63.12.4642-4652.1995</pub-id><pub-id pub-id-type="pmcid">PMC173667</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fern&#225;ndez</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fajardo</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Mandiarote</surname><given-names>A</given-names></name>, <name name-style="western"><surname>A&#241;o</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Padr&#243;n</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Acosta</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cabrera</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>River&#243;n</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>&#193;lvarez</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bla&#237;n</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fari&#241;as</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cardoso</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Garc&#237;a</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Campa</surname><given-names>C</given-names></name>, <name name-style="western"><surname>P&#233;rez</surname><given-names>JL</given-names></name></person-group><year>2013</year><article-title>A proteoliposome formulation derived from Bordetella pertussis induces protection in two murine challenge models</article-title>. <source>BMC Immunol</source><volume>14</volume>(<issue>Suppl 1</issue>):<fpage>S8</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2172-14-S1-S8</pub-id>.<pub-id pub-id-type="pmid">23458724</pub-id><pub-id pub-id-type="pmcid">PMC3582456</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Camacho</surname><given-names>AI</given-names></name>, <name name-style="western"><surname>Irache</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Gamazo</surname><given-names>C</given-names></name></person-group><year>2013</year><article-title>Recent progress towards development of a Shigella vaccine</article-title>. <source>Expert Rev Vaccines</source><volume>12</volume>:<fpage>43</fpage>&#8211;<lpage>55</lpage>. doi:<pub-id pub-id-type="doi">10.1586/erv.12.135</pub-id>.<pub-id pub-id-type="pmid">23256738</pub-id></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gehrmann</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Qazi</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Johansson</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hultenby</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Karlsson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lundeberg</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gabrielsson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Scheynius</surname><given-names>A</given-names></name></person-group><year>2011</year><article-title>Nanovesicles from Malassezia sympodialis and host exosomes induce cytokine responses&#8212;novel mechanisms for host-microbe interactions in atopic eczema</article-title>. <source>PLoS One</source><volume>6</volume>:<fpage>e21480</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0021480</pub-id>.<pub-id pub-id-type="pmid">21799736</pub-id><pub-id pub-id-type="pmcid">PMC3142114</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Freire-de-Lima</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Nosanchuk</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rodrigues</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Nimrichter</surname><given-names>L</given-names></name></person-group><year>2010</year><article-title>Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions</article-title>. <source>Infect Immun</source><volume>78</volume>:<fpage>1601</fpage>&#8211;<lpage>1609</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.01171-09</pub-id>.<pub-id pub-id-type="pmid">20145096</pub-id><pub-id pub-id-type="pmcid">PMC2849392</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodrigues</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Nakayasu</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Nimrichter</surname><given-names>L</given-names></name></person-group><year>2014</year><article-title>The impact of proteomics on the understanding of functions and biogenesis of fungal extracellular vesicles</article-title>. <source>J Proteomics</source><volume>97</volume>:<fpage>177</fpage>&#8211;<lpage>186</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jprot.2013.04.001</pub-id>.<pub-id pub-id-type="pmid">23583696</pub-id><pub-id pub-id-type="pmcid">PMC3745587</pub-id></mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>YC</given-names></name>, <name name-style="western"><surname>Kwon-Chung</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Jong</surname><given-names>A</given-names></name></person-group><year>2012</year><article-title>Cryptococcus neoformans-derived microvesicles enhance the pathogenesis of fungal brain infection</article-title>. <source>PLoS One</source><volume>7</volume>:<fpage>e48570</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0048570</pub-id>.<pub-id pub-id-type="pmid">23144903</pub-id><pub-id pub-id-type="pmcid">PMC3492498</pub-id></mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wormley</surname><given-names>FL</given-names><suffix>Jr.</suffix></name>, <name name-style="western"><surname>Perfect</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Steele</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cox</surname><given-names>GM</given-names></name></person-group><year>2007</year><article-title>Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain</article-title>. <source>Infect Immun</source><volume>75</volume>:<fpage>1453</fpage>&#8211;<lpage>1462</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.00274-06</pub-id>.<pub-id pub-id-type="pmid">17210668</pub-id><pub-id pub-id-type="pmcid">PMC1828544</pub-id></mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rella</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mor</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Farnoud</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Shamseddine</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Ivanova</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Carpino</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Montagna</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Luberto</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Del Poeta</surname><given-names>M</given-names></name></person-group><year>2015</year><article-title>Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development</article-title>. <source>Front Microbiol</source><volume>6</volume>:<fpage>836</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2015.00836</pub-id>.<pub-id pub-id-type="pmid">26322039</pub-id><pub-id pub-id-type="pmcid">PMC4531891</pub-id></mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donald</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Lamprecht</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Freestone</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Albrecht</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Bouic</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Kotze</surname><given-names>D</given-names></name>, <name name-style="western"><surname>van Jaarsveld</surname><given-names>PP</given-names></name></person-group><year>1997</year><article-title>A randomised placebo-controlled trial of the efficacy of beta-sitosterol and its glucoside as adjuvants in the treatment of pulmonary tuberculosis</article-title>. <source>Int J Tuberc Lung Dis</source><volume>1</volume>:<fpage>518</fpage>&#8211;<lpage>522</lpage>.<pub-id pub-id-type="pmid">9487449</pub-id></mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>Y</given-names></name></person-group><year>2006</year><article-title>Ginsenoside Rg1 helps mice resist to disseminated candidiasis by Th1 type differentiation of CD4<sup>+</sup> T cell</article-title>. <source>Int Immunopharmacol</source><volume>6</volume>:<fpage>1424</fpage>&#8211;<lpage>1430</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.intimp.2006.04.009</pub-id>.<pub-id pub-id-type="pmid">16846836</pub-id></mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>Y</given-names></name></person-group><year>2007</year><article-title>Immunoregulatory activity by daucosterol, a beta-sitosterol glycoside, induces protective Th1 immune response against disseminated candidiasis in mice</article-title>. <source>Vaccine</source><volume>25</volume>:<fpage>3834</fpage>&#8211;<lpage>3840</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2007.01.108</pub-id>.<pub-id pub-id-type="pmid">17335944</pub-id></mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bouic</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Etsebeth</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Liebenberg</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Albrecht</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Pegel</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Van Jaarsveld</surname><given-names>PP</given-names></name></person-group><year>1996</year><article-title>Beta-sitosterol and beta-sitosterol glucoside stimulate human peripheral blood lymphocyte proliferation: implications for their use as an immunomodulatory vitamin combination</article-title>. <source>Int J Immunopharmacol</source><volume>18</volume>:<fpage>693</fpage>&#8211;<lpage>700</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0192-0561(97)85551-8</pub-id>.<pub-id pub-id-type="pmid">9172012</pub-id></mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodrigues</surname><given-names>ML</given-names></name></person-group><year>2016</year><article-title>Funding and innovation in diseases of neglected populations: the paradox of cryptococcal meningitis. PLoS Negl Trop</article-title>. <source>Drosophila Inf Serv</source><volume>10</volume>:<fpage>e0004429</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pntd.0004429</pub-id><pub-id pub-id-type="pmcid">PMC4786104</pub-id><pub-id pub-id-type="pmid">26964103</pub-id></mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bassetti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Righi</surname><given-names>E</given-names></name></person-group><year>2015</year><article-title>Overview of fungal infections&#8212;the Italian experience</article-title>. <source>Semin Respir Crit Care Med</source><volume>36</volume>:<fpage>796</fpage>&#8211;<lpage>805</lpage>. doi:<pub-id pub-id-type="doi">10.1055/s-0035-1562890</pub-id>.<pub-id pub-id-type="pmid">26398544</pub-id></mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denning</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Bromley</surname><given-names>MJ</given-names></name></person-group><year>2015</year><article-title>Infectious disease. How to bolster the antifungal pipeline</article-title>. <source>Science</source><volume>347</volume>:<fpage>1414</fpage>&#8211;<lpage>1416</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aaa6097</pub-id>.<pub-id pub-id-type="pmid">25814567</pub-id></mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Wannemuehler</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Marston</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Govender</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Pappas</surname><given-names>PG</given-names></name>, <name name-style="western"><surname>Chiller</surname><given-names>TM</given-names></name></person-group><year>2009</year><article-title>Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS</article-title>. <source>AIDS</source><volume>23</volume>:<fpage>525</fpage>&#8211;<lpage>530</lpage>. doi:<pub-id pub-id-type="doi">10.1097/QAD.0b013e328322ffac</pub-id>.<pub-id pub-id-type="pmid">19182676</pub-id></mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vandeputte</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ferrari</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Coste</surname><given-names>AT</given-names></name></person-group><year>2012</year><article-title>Antifungal resistance and new strategies to control fungal infections</article-title>. <source>Int J Microbiol</source><volume>2012</volume>:<fpage>713687</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2012/713687</pub-id>.<pub-id pub-id-type="pmid">22187560</pub-id><pub-id pub-id-type="pmcid">PMC3236459</pub-id></mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>White</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Ibrahim</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Filler</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yeaman</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>JE</given-names><suffix>Jr.</suffix></name>, <name name-style="western"><surname>Hennessey</surname><given-names>JP</given-names><suffix>Jr.</suffix></name></person-group><year>2012</year><article-title>NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults</article-title>. <source>Vaccine</source><volume>30</volume>:<fpage>7594</fpage>&#8211;<lpage>7600</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2012.10.038</pub-id>.<pub-id pub-id-type="pmid">23099329</pub-id><pub-id pub-id-type="pmcid">PMC3513491</pub-id></mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Bernardis</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Amacker</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Arancia</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sandini</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gremion</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zurbriggen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Moser</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cassone</surname><given-names>A</given-names></name></person-group><year>2012</year><article-title>A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models</article-title>. <source>Vaccine</source><volume>30</volume>:<fpage>4490</fpage>&#8211;<lpage>4498</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2012.04.069</pub-id>.<pub-id pub-id-type="pmid">22561143</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>